- All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits.
- Wu HL, Luo ZY, He ZL, Gong Y, Mo M, Ming WK, Liu GY.
- Br J Cancer. 2022 Dec 23. doi: 10.1038/s41416-022-02111-y. Epub ahead of print.
- PMID: 36564566
- PubMed abstract